Zhang Hong-Mei, Dai Xing, Meng Ji-Hong, Zhao Yu, Shan Xiang-Nian
Department of Microbiology and Immunology, Southeast University School of Medicine, Nanjing 210009, China.
Yi Chuan. 2007 May;29(5):637-42. doi: 10.1360/yc-007-0637.
To characterize antigenic epitopes of hepatitis E virus (HEV) genotype 4 that was first identified in China a few years ago, a recombinant protein, p166Chn, encoded by HEV genotype 4 ORF2 was used to prepare anti-p166Chn McAbs. Simultaneously, twenty N- or C-terminal truncated p166Chn proteins were generated. Immunoreactivity between the McAbs and the truncated proteins as well as seven p166 recombinant proteins derived from different HEV genotypes and subgenotypes was detected by indirect ELISA, Western blot and competition inhibition ELISA. Two reactive profiles were observed with different McAbs and different truncated proteins. The McAbs, represented by 1G10, reacted with those N-terminal truncated proteins beginning at upstream of aa477 and those C-terminal truncated proteins ending at down-stream of aa613, suggesting that the epitope recognized by 1G10 relied on the region of aa477aa613 and was conformation-dependent. While McAb 2F11 was reactive to those truncated p166Chn proteins beginning at upstream of aa474 or ending at downstream of aa617, indicating that the epitope recognized by 2F11 was also conformation-dependent and relied on a longer peptide of aa474aa617. However, the two groups of McAbs didn't inhibit each other when tested by a competition inhibition ELISA, which confirmed the different spatial positions of the two epitopes. Furthermore, when p166 proteins derived from different HEV genotypes and subtypes were applied, all of the McAbs prepared against pChn166 of genotype 4 identified in China could react with the proteins of genotype 1, 2 and 3 distributed worldwide. The data suggested that the two identified epitopes were HEV genotype-common and played significant effects on cross immunoreactivity between different HEV genotypes.
为了鉴定几年前首次在中国发现的戊型肝炎病毒(HEV)基因4型的抗原表位,用HEV基因4型开放阅读框2(ORF2)编码的重组蛋白p166Chn制备抗p166Chn单克隆抗体(McAbs)。同时,构建了20种N端或C端截短的p166Chn蛋白。通过间接酶联免疫吸附测定(ELISA)、蛋白质免疫印迹法(Western blot)和竞争抑制ELISA检测这些单克隆抗体与截短蛋白以及7种源自不同HEV基因型和亚基因型的p166重组蛋白之间的免疫反应性。不同的单克隆抗体和不同的截短蛋白呈现出两种反应模式。以1G10为代表的单克隆抗体与起始于第477位氨基酸上游的N端截短蛋白以及终止于第613位氨基酸下游的C端截短蛋白发生反应,这表明1G10识别的表位依赖于第477-613位氨基酸区域,且为构象依赖性。而单克隆抗体2F11与起始于第474位氨基酸上游或终止于第617位氨基酸下游的截短p166Chn蛋白发生反应,这表明2F11识别的表位也是构象依赖性的,且依赖于更长的第474-617位氨基酸肽段。然而,通过竞争抑制ELISA检测时,这两组单克隆抗体之间并未相互抑制,这证实了两个表位的空间位置不同。此外,当应用源自不同HEV基因型和亚型的p166蛋白时,所有针对在中国鉴定出的基因4型pChn166制备的单克隆抗体均可与全球分布的基因1型、2型和3型蛋白发生反应。这些数据表明,所鉴定出的两个表位是HEV基因型共有的,且在不同HEV基因型之间的交叉免疫反应中发挥重要作用。